Levofloxacina Tecnigen Italia (Levofloxacin)

Levofloxacina Tecnigen Italia is a fluoroquinolone antibiotic used to treat bacterial infections in several organ systems.

• Community‑acquired respiratory tract infection: effective bacterial eradication in acute lung and airway infections.
• Acute bacterial sinusitis: clears sinus pathogens and relieves sinus inflammation.
• Acute exacerbation of chronic bronchitis: reduces bacterial load and improves breathing function.
• Uncomplicated urinary tract infection: eliminates uropathogens causing cystitis.
• Skin and soft‑tissue infection: combats Gram‑negative and Gram‑positive skin pathogens.
• Prostatitis: penetrates prostatic tissue to treat bacterial inflammation.

• Levofloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA replication, transcription, and repair. By stabilizing the enzyme‑DNA complex, it prevents the resealing of DNA strands, leading to bacterial cell death. This bactericidal action is broad‑spectrum, affecting both Gram‑negative and Gram‑positive organisms.

Levofloxacina Tecnigen Italia may cause a range of adverse reactions.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Diarrhea: loose stools, sometimes watery.
• Headache: transient cranial discomfort.
• Dizziness: sensation of light‑headedness.
• Abdominal pain: cramping or discomfort in the stomach area.
• Rash: mild skin redness or itching.

Serious or Rare Side Effects

• Tendon rupture: sudden tendon pain or loss of function, especially in the Achilles.
• QT interval prolongation: risk of cardiac arrhythmias.
• Severe allergic reactions: anaphylaxis, swelling, or hives.
• Clostridioides difficile infection: severe colitis with watery diarrhea.
• Hepatic toxicity: elevated liver enzymes or jaundice.
• Peripheral neuropathy: numbness or tingling in extremities.

Before prescribing Levofloxacina Tecnigen Italia, clinicians should consider several safety measures.

• Assess renal function: adjust therapy in patients with severe impairment.
• Avoid use in patients with known hypersensitivity to fluoroquinolones.
• Monitor for tendon pain: discontinue if signs of tendinitis or rupture appear.
• Use caution in elderly: higher incidence of CNS effects such as confusion.
• Avoid concomitant use with other QT‑prolonging agents: increased arrhythmia risk.
• Store at ambient temperature: keep in original container, protect from moisture and light.

Levofloxacina Tecnigen Italia can interact with other medicines, requiring careful management.

Major Interactions (Avoid)

• Antacids containing magnesium or aluminum: markedly reduce levofloxacin absorption.
• Warfarin: potentiates anticoagulant effect, increasing bleeding risk.
• Other fluoroquinolones: additive toxicity, especially tendon and CNS effects.

Moderate Interactions (Monitor Closely)

• NSAIDs: may enhance central nervous system stimulation.
• Theophylline: levofloxacin can increase serum theophylline levels, risking toxicity.
• Diabetes medications: possible alteration of glucose control, requiring monitoring.